The bactericidal activity of 23 I-lactam antibiotics was compared in slowly growing bacteria cultured in a chemostat. In an attempt to mimic possible in vivo conditions, slowly growing cultures were produced by limitation of iron, glucose, phosphate, or magnesium. Only select antibiotics remained effectively bactericidal against slowly growing cells. For these compounds, the rate of antibiotic-induced loss of viability was a constant when killing was expressed per generation (in contrast to absolute time) in that slowly growing bacteria were killed proportionately more slowly. Individual antibiotics differed greatly, however, in their specific bactericidal activities against slowly growing cells, i.e., in the absolute degree of killing elicited during exposure of the bacteria to MIC equivalents of the drugs. Specific bactericidal activities varied not only with drug structure but also with the bacterial strains and, to a lesser extent, with the nature of the growth-limiting nutrient. In slowly growing cultures exposure to the low drug concentrations studied here (near MIC) caused killing without detectable lysis. Antibiotics with high specific bactericidal activities were capable of rapidly killing cultures of slowly growing pathogens despite extremely long generation times approaching those reported for in vivo growth rates.
The in vitro bactericidal activity of an antibiotic does not always correlate with therapeutic efficacy. The reasons for this lack of correlation are likely to be multiple (35) . One explanation which has received only recent attention is the probable phenotypic differences between bacteria growing in the nutritionally limited in vivo environment and those growing under optimum conditions in the laboratory. Phenotypically induced changes in microorganisms have been shown to alter markedly their susceptibility to the bactericidal activity of antimicrobial agents; these changes include alterations in drug permeability across the outer or cytoplasmic membranes (3, 7, 14) , alterations in the structure of peptidoglycan such that it resists degradative enzymes (17, 23, 26, 28) , or alteration of penicillin-binding proteins (4, 9, 13, 25) .
A slow growth rate (12, 22, 24) and a restricted availability of iron (5, 33) and possibly other nutrients appear to be characteristic of many infections in vivo. These two parameters could be major contributors to phenotypic tolerance (i.e., relative insensitivity to the bactericidal effect of drugs) in vivo (E. Tuomanen, Rev. Infect. Dis., in press). Since the earliest days of the antibiotic era it has been recognized that slowly growing bacteria are less susceptible to antibiotic action than those growing at optimum rates (16) .
The chemostat has already proved useful in studies of the effect of growth rate and nutritional status of microorganisms on their susceptibility to antimicrobial agents (8, 14, 19, 20, 29) . The purpose of the study described here was to compare the bactericidal activity of a range of 1-lactam antibiotics on several species of bacteria growing at reduced rates in the chemostat under conditions mimicking those of in vivo environments, such as growth limitation by the supply of iron, glucose, phosphate, or magnesium. Several compounds, including MT 141 [7,8- 216, 1984) , and most congeners of CGP 17520 were found to be exceptional in that they retained superior bactericidal activity against slowly growing cultures of several pathogens. This activity may contribute to the unexpectedly high in vivo efficacy of these agents, an activity not predicted from conventional in vitro testing.
MATERIALS AND METHODS
Bacteria. All of the bacteria used in this study were obtained from the CIBA-GEIGY culture collection. The organisms were maintained in the gaseous phase above liquid nitrogen (-150°C) after overnight culture. Before use the bacteria were cultured overnight on brain heart infusion agar (with 5 ,ug of diaminopimelic acid per ml for Escherichia coli W7, a diaminopimelic acid-lysine auxotroph) to check for purity.
Chemicals. All chemicals for media were of the purest grades available from normal commercial sources. All CGP compounds, cefonicid, mecillinam, and nocardicin were synthesized in the Chemistry Department at CIBA-GEIGY. MT 141 was kindly provided by Meiji-Seika, Japan. All other antibiotics were from commercial sources.
Growth in chemostats. The chemostat consists of a culture vessel with a suitable method of adding fresh medium at a constant rate (the rate of flow determines the growth rate); a constant level device removes bacteria and spent medium at the same rate. The medium is constructed so that one essential nutrient is present in growth-limiting amounts and all other components are in excess. The concentration of this limiting nutrient determines the bacterial mass at the steady state. A full description of a chemostat and a consideration of the theoretical aspects have been given by Calcott (6) and Bazin (1) , respectively.
In the present study all-glass chemostats (50-ml working volume) were employed. The chemostats were based on the design of Gilbert and Stuart (15), with one major modification; the exhaust gas condenser was replaced by a simple weir, and sterile incoming air was humidified by sparging through sterile, double-distilled water.
The growth medium had the following full-strength composition: glucose, 10 Bacteria grown overnight on brain heart infusion agar and then suspended in normal saline were used for inoculation of the chemostats. The medium flow was started when growth was seen. The chemostats were allowed to stabilize for 10 doubling times, at which point susceptibility tests were commenced. Throughout the experiments the incubation temperature was maintained at 37°C.
Susceptibility tests. The antibiotics were dissolved in the appropriate medium and sterilized by membrane filtration. The antibiotic was added, in as small a volume as possible, to the chemostat culture; simultaneously the inflowing medium was changed to one containing antibiotic. In this manner the antibiotic concentration was brought to the required level instantly and maintained at that level for the duration of the experiment. At suitable time intervals samples were collected from the overflow and viable counts, total counts, and cell size distributions were determined. Viable counts were determined after dilution in normal saline and inoculation of the surface of brain heart infusion agar plates with 0.05-ml drops (in triplicate). Colonies were counted after 24 h of incubation at 37°C. Total counts were determined in a model TAII Coulter Counter after dilution (1:2) in 5% (vol/vol) formaldehyde in normal saline. A Population Count Accessory attached to the Coulter Counter allowed the simultaneous determination of cell size distributions.
Electron microscopy. To 1 ml of bacterial suspension was added 1 ml of cacodylate buffer (0.1 M, pH 7.4) containing 3% glutaraldehyde. The tubes were left in crushed ice for 30 min. Thereafter, the samples were centrifuged (10,000 x g, 2 min), and the supernatant was replaced by fresh cacodylate buffer containing 3% glutaraldehyde. After 24 h the sediment was postfixed for 2 h with 1% osmium tetroxide in cacodylate buffer and, after dehydration in graded acetone concentrations, embedded in Epon resin (21) . After polymerization, the blocks were sectioned with a Reichert Ultracut ultramicrotome. Contrast was enhanced by double staining with uranyl acetate and lead citrate (27) . The sections were examined in a Philips EM-300 electron microscope, and micrographs were recorded on 6.5-by 9-cm films. Effect of growth rate on the activity of CGP 17520 and ceftriaxone against E. coli 205. In all cases E. coli 205 bacteria were killed more quickly at the higher growth rates (Fig. 1) wide range under otherwise constant conditions. Chemostat cultures are therefore an invaluable tool in efforts to study the effects of reduced growth rates characteristic of bacteria growing in vivo. We have used chemostat cultures to investigate the effect of reductions in growth rate on antibiotic activity. The results presented herein show that the bactericidal activity of a wide range of cell wall-active antibiotics is critically dependent on growth rate. This is true, for the most part, regardless of the nature of the limiting nutrient. However, antibiotics differ in the degree to which their activities are effected by growth rate. Ceftazidime, ceftriaxone, and ceftizoxime, which may be considered to be among the most rapidly bactericidal agents of the present generation of cephalosporins in in vitro tests against rapidly growing bacteria, are not bactericidal against slow-growing cells. Indeed only a modest decrease in growth rate leads to a virtually complete loss of the bactericidal activity of ceftriaxone (Fig. 1B) . Perhaps the most important observation noted in our study is that the loss of killing ability against slowly growing bacteria is not observed with all antibiotics. For example, CGP 17520, although affected by growth rate, was still markedly bactericidal against E. coli growing extremely slowly (Fig. 1A) . This observation may account, at least in part, for its unexpectedly good in vivo activity. Similarly, most congeners of CGP 17520 and MT 141, which has been shown to have activity in vivo better than that expected from in vitro testing (18) , also retained significant bactericidal activity as growth rate was reduced. These findings are in agreement with studies on nongrowing cells deprived of an essential amino acid (Tuomanen, in press). In that system the same antibiotics were shown to retain extraordinarily high bactericidal activity despite a complete absence of bacterial growth. The lack of activity of conventional ,-lactam antibiotics against nongrowing bacteria is a well-known phenomenon termed phenotypic tolerance (Tuomanen, in press (4, 9, 10, 13, 17, 23, 25, 26, 28) . These features may also contribute to the observed differences in the relative killing activity of various f3-lactam antibiotics against slowly growing bacteria. The presence of an amino acid residue on the C7 position of the cephalosporin nucleus (a common feature of MT 141 and the CGP compounds) appears to endow some of the compounds with relatively good activity against slowly growing bacteria. Further testing of similar compounds is required, however, before a structure-activity relationship can be deduced.
RESULTS
Rapidly growing cultures of most enterobacteria undergo lysis in conjunction with the bactericidal activity of many 3-lactam antibiotics. In the experiments described here bacterial death was not accompanied by lysis when slowly growing bacteria were treated with low concentrations of all antibiotics tested. Even at the fastest growth rate (generation time, 1.5 h), at which the generation time was only twice that of batch cultures (ca. 50 min), no measurable lysis was detectable either by the Coulter Counter or by direct microscopic observation. On the other hand, we have shown that higher concentrations of several of the agents tested do induce lysis of these same slowly growing cells (Tuomanen et al., in press). The dissociation of bacterial death from lysis has been noted in tolerant mutants which have defective autolytic enzymes (31) . The mechanism of the slow death of these cells in response to penicillin is not understood. Our data suggest that even in bacteria with active autolytic enzymes (such as the strains used in these experiments) it is possible to dissociate bacterial death from lysis by altering the growth rate. The possibility exists therefore that under some circumstances (low antibiotic concentrations and slowgrowing cells) bacterial lysis may be a less prominent feature of bacterial death in vivo than in vitro. This may have bearing on the therapy of certain infections, e.g., meningitis, since the bacterial cell wall is known to be a significant mediator of inflammation (32) .
It is now widely accepted that for the successful therapy of many infections, particularly those in compromised hosts, a bactericidal antibiotic is desirable. If, as seems probable, bacteria grow slowly in the host (12, 22, 24) , then our results suggest that many antibiotics will be merely bacteriostatic. This may account, at least in part, for the relapses which occur on the withdrawal of antibiotic therapy. We have shown that antibiotics exist which have the capability of killing slow-growing bacteria. It should be possible to produce antibiotics having this characteristic together with suitable pharmacokinetic and other properties. Such antibiotics would be expected to have a distinct therapeutic advantage.
